These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38326656)

  • 1. Preclinical study and first-in-human imaging of [
    Liu L; Zhong J; Zhang Z; Ye X; Wang X; Liu S; Zhang Z
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2012-2022. PubMed ID: 38326656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of [
    Liu N; Wan Q; Wu X; Zhao T; Jakobsson V; Yuan H; Chen X; Zhang J; Zhang W
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1685-1697. PubMed ID: 38246909
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
    J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
    Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
    J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Liu S; Zhong J; Zhang Z; Zhao R; Yan Q; Wang X
    Eur J Nucl Med Mol Imaging; 2024 Oct; 51(12):3651-3661. PubMed ID: 38910166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical translation of a novel FAPI dimer [
    Tan Y; Li J; Zhao T; Zhou M; Liu K; Xiang S; Tang Y; Jakobsson V; Xu P; Chen X; Zhang J
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2761-2773. PubMed ID: 38561515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-Head Comparison of [
    Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
    Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [
    Huang J; Fu L; Zhang X; Huang S; Dong Y; Hu K; Han Y; Zhou K; Min C; Huang Y; Tang G
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3363-3374. PubMed ID: 37266596
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kline B; Yadav S; Seo Y; Ippisch RC; Castillo J; Aggarwal RR; Kelley RK; Behr SC; Flavell RR; Lawhn-Heath C; Melisko M; Rugo HS; Wang V; Yom SS; Ha P; Jiang F; Hope TA
    J Nucl Med; 2024 Jun; 65(6):938-943. PubMed ID: 38697672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rationally designed nuclei-targeting FAPI 04-based molecular probe with enhanced tumor uptake for PET/CT and fluorescence imaging.
    Zhao X; Zhang G; Chen J; Li Z; Shi Y; Li G; Zhai C; Nie L
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1593-1604. PubMed ID: 38512485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [
    Du X; Gu B; Wang X; Wang X; Ji M; Zhang J; He S; Xu X; Yang Z; Song S
    Mol Pharm; 2024 Feb; 21(2):904-915. PubMed ID: 38179677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [
    Linz C; Brands RC; Kertels O; Dierks A; Brumberg J; Gerhard-Hartmann E; Hartmann S; Schirbel A; Serfling S; Zhi Y; Buck AK; Kübler A; Hohm J; Lapa C; Kircher M
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3951-3960. PubMed ID: 34050405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical translational evaluation of Al
    Wang S; Zhou X; Xu X; Ding J; Liu S; Hou X; Li N; Zhu H; Yang Z
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4259-4271. PubMed ID: 34165601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosynthesis, preclinical evaluation and pilot clinical PET imaging study of a
    Fu L; Huang J; Liu Q; Xie F; Han Y; Sun P; Cao M; Huang Y; Hu K; Tang G
    Bioorg Chem; 2023 Dec; 141():106878. PubMed ID: 37774434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of
    Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
    Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [
    Wei Y; Zheng J; Ma L; Liu X; Xu S; Wang S; Pei J; Cheng K; Yuan S; Yu J
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2761-2773. PubMed ID: 35262766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.
    Yang T; Peng L; Qiu J; He X; Zhang D; Wu R; Liu J; Zhang X; Zha Z
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2331-2341. PubMed ID: 36864362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
    Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.